| [1] |
Du CZ,Li J,Cai Y,et al. Effect of multidisciplinary teamtreatment on outcomes of patients with gastro intestinal malignancy[J]. World J Gastroenterol, 2010, 17(15): 2013-2018.
|
| [2] |
Chen MB,Wu XY,Yu R, et al. P53 status as a predictive biomarker for patientsreceiving neoadjuvant radiation-based treatment: a meta-analysis in rectal cancer[J]. PLoS One, 2012, 7(9): e45388.
|
| [3] |
Duldulao MP,Lee W,Nelson RA, et al. Mutations in specific codons of theKRAS oncogene are associated with variable resistance to neoadjuvant chemoradiation therapy in patients with rectal adenocarcinoma[J]. Ann Surg Oncol, 2013, 20(7): 2166-2171.
|
| [4] |
Bengala C,Bettelli S,Bertolini F, et al. Prognostic role of EGFR gene copynumber and KRAS mutation in patients with locally advanced rectal cancertreated with preoperative chemoradiotherapy[J]. Br J Cancer, 2010, 103(7): 1019-1024.
|
| [5] |
Gaedcke J,Grade M,Jung K, et al. KRAS and BRAF mutations in patients withrectal cancer treated with preoperative chemoradiotherapy[J]. Radiother Oncol, 2010, 94(1): 76-81.
|
| [6] |
Luna-Perez P,Segura J,Alvarado I, et al. Specific c-K-ras gene mutations as atumor-response marker in locally advanced rectal cancer treated with preoperativechemoradiotherapy[J]. Ann Surg Oncol, 2000, 7(10): 727-731.
|
| [7] |
Hur H,Kang J,Kim NK, et al. Thymidylate synthase gene polymorphism affectsthe response to preoperative 5-fluorouracil chemoradiation therapy in patientswith rectal cancer[J]. Int J Radiat Oncol Biol Phys, 2011, 81(3): 669-676.
|
| [8] |
Cecchin E,Agostini M,Pucciarelli S, et al. Tumor response is predicted bypatient genetic profile in rectal cancer patients treated with neo-adjuvant chemoradiotherapy[J]. Pharmacogenomics J, 2011, 11(3): 214-226.
|
| [9] |
Grade M,Gaedcke J,Wangsa D, et al. Chromosomal copy number changes oflocally advanced rectal cancers treated with preoperative chemoradiotherapy[J]. Cancer Genet Cytogenet, 2009, 193(1): 19-28.
|
| [10] |
Chen Z,Liu Z,Li W, et al. Chromosomal copy number alterations are associatedwith tumor response to chemoradiation in locally advanced rectal cancer[J]. GenesChromosomes Cancer, 2011, 50(9): 689-699.
|
| [11] |
Zaki BI,Suriawinata AA,Eastman AR, et al. Chromosomal instability portendssuperior response of rectal adenocarcinoma to chemoradiation therapy[J]. Cancer, 2014, 120(11): 1733-1742.
|
| [12] |
Ghadimi BM,Grade M,Difilippantonio MJ, et al. Effectiveness of gene expression profiling for response prediction of rectal adenocarcinomas to preoperative chemoradiotherapy[J]. J Clin Oncol, 2005, 23(9): 1826-1838.
|
| [13] |
Palma P,Cano C,Conde-Muino R, et al. Expression profiling of rectal tumors defines response to neoadjuvant treatment related genes[J]. PLoS One, 2014, 9(11): e112189.
|
| [14] |
Gantt GA,Chen Y,Dejulius K, et al. Gene expression profile is associated withchemoradiation resistance in rectal cancer[J]. Colorectal Dis, 2014, 16(1): 57-66.
|
| [15] |
Akiyoshi T,Kobunai T,Watanabe T. Predicting the response to preoperativeradiation or chemoradiation by a microarray analysis of the gene expressionprofiles in rectal cancer[J]. Surg Today, 2012, 42(8): 713-719.
|
| [16] |
Watanabe T,Kobunai T,Akiyoshi T, et al. Prediction of response to preoperativechemoradiotherapy in rectal cancer by using reverse transcriptase polymerasechain reaction analysis of four genes[J]. Dis Colon Rectum, 2014, 57(1): 23-31.
|
| [17] |
Zielske SP. Epigenetic DNA methylation in radiation biology: on the field or onthe sidelines[J]? J Cell Biochem, 2015, 116(2): 212-217.
|
| [18] |
Jo P,Jung K,Grade M, et al. CpG island methylator phenotype infers apoor disease-free survival in locally advanced rectal cancer[J]. Surgery, 2012, 151(4): 564-570.
|
| [19] |
Molinari C,Casadio V,Foca F, et al. Gene methylation in rectal cancer: predictive marker of response to chemoradiotherapy[J]? J Cell Physiol, 2013, 228(12): 2343-2349.
|
| [20] |
Drebber U,Lay M,Wedemeyer I, et al. Altered levels of the onco-microRNA21 and the tumor-supressor microRNAs 143 and 145 in advanced rectalcancer indicate successful neoadjuvant chemoradiotherapy[J]. Int J Oncol, 2011, 39(2): 409-415.
|
| [21] |
Della Vittoria Scarpati G,Falcetta F,Carlomagno C, et al. A specific miRNAsignature correlates with complete pathological response to neoadjuvant chemoradiotherapyin locally advanced rectal cancer[J]. Int J Radiat Oncol Biol Phys, 2012, 83(4): 1113-1119.
|
| [22] |
Svoboda M,Izakovicova Holla L,Sefr R, et al. Micro-RNAs miR125b and miR137 are frequently upregulated in response to capecitabine chemoradiotherapyof rectal cancer[J]. Int J Oncol, 2008, 33(3): 541-547.
|
| [23] |
Svoboda M,Sana J,Fabian P, et al. MicroRNA expression profile associated withresponse to neoadjuvant chemoradiotherapy in locally advanced rectal cancerpatients[J]. Radiat Oncol, 2012, 7(1):195.
|
| [24] |
Bandres E,Arias F,Guerrero D, et al. Association between a specific miRNAsignature and pathological response to neoadjuvant chemoradiotherapy (CRT) inlocally advanced rectal cancer (LARC) patients (abstract e14057)[J]. J Clin Oncol, 2012, 30(15 suppl): e14057.
|
| [25] |
Meng X,Huang Z,Wang R, et al. Prediction of response to preoperative chemoradiotherapy in patients with locally advanced rectal cancer[J]. Biosci Trends, 2014, 8(1): 11-23.
|
| [26] |
Hur H,Kim NK,Min BS, et al. Can a biomarker-based scoring system predictpathologic complete response after preoperative chemoradiotherapy for rectalcancer[J]? Dis Colon Rectum, 2014, 57(5): 592-601.
|
| [27] |
Drebber U,Madeja M,Odenthal M, et al. Beta-catenin and HER2/neu expression in rectal cancer: association with histomorphological response toneoadjuvant therapy and prognosis[J]. Int J Colorectal Dis, 2011, 26(9): 1127-1134.
|
| [28] |
Bhangu A,Wood G,Brown G, et al. The role of epithelial mesenchymal transitionand resistance to neoadjuvant therapy in locally advanced rectal cancer[J]. Colorectal Dis, 2014, 16(4): 0133-0143.
|
| [29] |
Wang L,Zhang XM,Li Z, et al. Overexpression of nuclear beta-catenin in rectaladenocarcinoma is associated with radioresistance[J]. World J Gastroenterol, 2013, 19(40): 6876-6882.
|
| [30] |
Gillet JP,Efferth T,Remacle J. Chemotherapy-induced resistance by ATPbindingcassette transporter genes[J]. Biochim Biophys Acta, 2007, 1775(2): 237-262.
|
| [31] |
Yu ZQ,Zhang C,Wang H, et al. Downregulation of ATP-binding cassette subfamily C member 4 increases sensitivity to neoadjuvant radiotherapy forlocally advanced rectal carcinoma[J]. Dis Colon Rectum, 2013, 56(5): 600-608.
|
| [32] |
Yu Z,Zhang C,Chai R, et al. Prognostic significance and molecular mechanismof ATP-binding cassette subfamily C member 4 in resistance to neoadjuvantradiotherapy of locally advanced rectal carcinoma[J]. PLoS One, 2014, 9(1): e85446.
|
| [33] |
Yu Z,Zhang C,Wang H, et al. Multidrug resistance-associated protein 3 confers resistance to chemoradiotherapy for rectal cancer by regulating reactiveoxygen species and caspase-3-dependent apoptotic pathway[J]. Cancer Lett, 2014, 353(2): 182-193.
|
| [34] |
Das P,Skibber JM,Rodriguez-Bigas MA, et al. Predictors of tumor response anddownstaging in patients who receive preoperative chemoradiation for rectalcancer[J]. Cancer, 2007, 109(9): 1750-1755.
|
| [35] |
Yang KL,Yang SH,Liang WY, et al. Carcinoembryonic antigen (CEA) level,CEA ratio, and treatment outcome of rectal cancer patients receiving preoperativechemoradiation and surgery[J]. Radiat Oncol, 2013, 8: 43.
|
| [36] |
Zitt M,Muller HM,Rochel M, et al. Circulating cell-free DNA in plasma of locally advanced rectal cancer patients undergoing preoperative chemoradiation:a potential diagnostic tool for therapy monitoring[J]. Dis Markers, 2008, 25(3): 159-165.
|
| [37] |
Agostini M,Pucciarelli S,Enzo MV, et al. Circulating cell-free DNA: a promisingmarker of pathologic tumor response in rectal cancer patients receiving preoperativechemoradiotherapy[J]. Ann Surg Oncol, 2011, 18(9): 2461-2468.
|
| [38] |
Terrin L,Rampazzo E,Pucciarelli S, et al. Relationship between tumor and plasma levels of hTERT mRNA in patients with colorectal cancer: implicationsfor monitoring of neoplastic disease[J]. Clin Cancer Res, 2008, 14(22): 7444-7451.
|
| [39] |
Pucciarelli S,Rampazzo E,Briarava M, et al. Telomere-specific reverse transcriptase(hTERT) and cell-free RNA in plasma as predictors of pathologic tumorresponse in rectal cancer patients receiving neoadjuvant chemoradiotherapy[J]. AnnSurg Oncol, 2012, 19(9): 3089-3096.
|
| [40] |
Smith FM,Gallagher WM,Fox E, et al. Combination of SELDI-TOF-MS and data mining provides early-stage response prediction for rectal tumorsundergoing multimodal neoadjuvant therapy[J]. Ann Surg, 2007, 245(2): 259-266.
|
| [41] |
Palma P,Cuadros M,Conde-Muino R, et al. Microarray profiling of mononuclearperipheral blood cells identifies novel candidate genes related to chemoradiationresponse in rectal cancer[J]. PLoS One, 2013, 8(9): e74034.
|